Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Ryom

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|November 5, 2020
Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk ScoresLéna G Dietrich, Christian W Thorball, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.
Kidney International|November 22, 2024
Corrigendum to "Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV." Kidney International 2024;106:136-144Annegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
AIDS (London, England)|March 8, 2016
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
Kidney International|May 2, 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIVAnnegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trialAmit C Achhra, Amanda Mocroft, Michael Ross, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|November 5, 2020
Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk ScoresLéna G Dietrich, Christian W Thorball, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.
Kidney International|November 22, 2024
Corrigendum to "Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV." Kidney International 2024;106:136-144Annegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
AIDS (London, England)|March 8, 2016
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
Kidney International|May 2, 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIVAnnegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trialAmit C Achhra, Amanda Mocroft, Michael Ross, et al.
Pageof 11